Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing

    Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing

    FromBlood & Cancer

    Start listeningView podcast show

    Hem-Onc News: Delaying radiotherapy for high-risk prostate cancer; melanoma experts say 'no' to routine gene profile testing

    FromBlood & Cancer

    ratings:
    Length:
    12 minutes
    Released:
    Sep 8, 2020
    Format:
    Podcast episode

    Description

    Blood & Cancer News:   Delaying RT for higher-risk prostate cancer found safe: https://bit.ly/2F1cKoQ Source: https://bit.ly/2FaaMCr RTOG 9413: https://bit.ly/2DL2FM4 RTOG 9910: https://bit.ly/2F8itJe HOME-PE trial clarifies which pulmonary embolism patients to treat at home: https://bit.ly/3ibNTN9 Melanoma experts say ‘no’ to routine gene profile testing: https://bit.ly/2Zka10p Source: https://bit.ly/2ZkzerB  VTE, sepsis risk increased among COVID-19 patients with cancer: https://bit.ly/2DL2Wi4 You can learn more about Blood & Cancer at https://www.mdedge.com/podcasts/blood-cancer
    Released:
    Sep 8, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.